115 related articles for article (PubMed ID: 26093131)
1. [Radiofrequency in the treatment of the renal neoplasias].
Fiorini F; Granata A; Mereghetti M; D'Amelio A; Meloni MF
G Ital Nefrol; 2015; 32(3):. PubMed ID: 26093131
[TBL] [Abstract][Full Text] [Related]
2. Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience.
Zlotta AR; Wildschutz T; Raviv G; Peny MO; van Gansbeke D; Noel JC; Schulman CC
J Endourol; 1997 Aug; 11(4):251-8. PubMed ID: 9376843
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous ultrasound-guided radiofrequency ablation treatment and genetic testing for renal cell carcinoma with Von Hippel-Lindau disease.
Gao Y; Xu M; Xu ZF; Liu DW; Tu XA; Zheng YL; Wang DH; Sun XZ; Zheng FF; Qiu SP; Lü MD; Zhang YY; Xie XY; Deng CH
J Xray Sci Technol; 2012; 20(1):121-9. PubMed ID: 22398592
[TBL] [Abstract][Full Text] [Related]
4. Treatment of renal tumors by percutaneous ultrasound-guided radiofrequency ablation using a multitined electrode: effectiveness and complications.
del Cura JL; Zabala R; Iriarte JI; Unda M
Eur Urol; 2010 Mar; 57(3):459-65. PubMed ID: 19926208
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease previously undergoing a radical nephrectomy or repeated nephron-sparing surgery.
Park SY; Park BK; Kim CK; Lee HM; Jeon SS; Seo SI; Jeong BC; Choi HY
Acta Radiol; 2011 Jul; 52(6):680-5. PubMed ID: 21525107
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous radio frequency ablation of renal tumors in patients with von Hippel-Lindau disease: preliminary results.
Park BK; Kim CK
J Urol; 2010 May; 183(5):1703-7. PubMed ID: 20299060
[TBL] [Abstract][Full Text] [Related]
7. Imaging-guided radiofrequency ablation of solid renal tumors.
Farrell MA; Charboneau WJ; DiMarco DS; Chow GK; Zincke H; Callstrom MR; Lewis BD; Lee RA; Reading CC
AJR Am J Roentgenol; 2003 Jun; 180(6):1509-13. PubMed ID: 12760910
[TBL] [Abstract][Full Text] [Related]
8. The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease.
Duffey BG; Choyke PL; Glenn G; Grubb RL; Venzon D; Linehan WM; Walther MM
J Urol; 2004 Jul; 172(1):63-5. PubMed ID: 15201738
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous ultrasound-guided radiofrequency ablation of recurrent renal cell carcinoma in renal allograft after partial nephrectomy.
Goeman L; Joniau S; Oyen R; Van Poppel H
Urology; 2006 Jan; 67(1):199. PubMed ID: 16413367
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma in patients with a solitary kidney after nephrectomy treated with radiofrequency ablation: mid term results.
Hoffmann RT; Jakobs TF; Kubisch CH; Trumm C; Weber C; Siebels M; Helmberger TK; Reiser MF
Eur J Radiol; 2010 Mar; 73(3):652-6. PubMed ID: 19181470
[TBL] [Abstract][Full Text] [Related]
11. First prize: direct real-time temperature monitoring for laparoscopic and CT-guided radiofrequency ablation of renal tumors between 3 and 5 cm.
Carey RI; Leveillee RJ
J Endourol; 2007 Aug; 21(8):807-13. PubMed ID: 17867933
[TBL] [Abstract][Full Text] [Related]
12. Management of small solitary unilateral renal cell carcinomas: impact of central versus peripheral tumor location.
Hafez KS; Novick AC; Butler BP
J Urol; 1998 Apr; 159(4):1156-60. PubMed ID: 9507821
[TBL] [Abstract][Full Text] [Related]
13. Nephron-sparing surgery for renal cell carcinoma in the solitary kidney.
Berdjis N; Hakenberg OW; Novotny V; Manseck A; Oehlschläger S; Wirth MP
Scand J Urol Nephrol; 2007; 41(1):10-3. PubMed ID: 17366096
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
[TBL] [Abstract][Full Text] [Related]
15. [Nephron-sparing surgery--initial experience with 50 patients].
Halachmi S; Kastin A; Moskovitz B; Nativ O
Harefuah; 1999 Jun; 136(12):919-23, 1004. PubMed ID: 10955147
[TBL] [Abstract][Full Text] [Related]
16. [Nephron-sparing surgery for small renal cell carcinoma: clinical analysis of 21 cases].
Xiao YJ; Zheng SB; Tan WL; Chen T; Qi H; Shao ZQ; Jiang YD; Wu P; Zhang HJ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):357-9. PubMed ID: 15772014
[TBL] [Abstract][Full Text] [Related]
17. Computed tomography-guided, resistance-based, percutaneous radiofrequency ablation of renal malignancies under conscious sedation at two years of follow-up.
Arzola J; Baughman SM; Hernandez J; Bishoff JT
Urology; 2006 Nov; 68(5):983-7. PubMed ID: 17095059
[TBL] [Abstract][Full Text] [Related]
18. Review of radiofrequency ablation for renal cell carcinoma.
Hines-Peralta A; Goldberg SN
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6328S-34S. PubMed ID: 15448026
[TBL] [Abstract][Full Text] [Related]
19. Expanding indication for elective nephron-sparing surgery in renal cell carcinoma.
Ficarra V; Secco S; Fracalanza S; Novara G; Gidaro S; Cindolo L; Schips L
Arch Ital Urol Androl; 2009 Jun; 81(2):86-90. PubMed ID: 19760862
[TBL] [Abstract][Full Text] [Related]
20. Incidence and treatment of complications in nephron sparing surgery.
Seveso M; Maugeri O; Taverna G; Giusti G; Piccinelli A; Benetti A; Pasini L; Graziotti P
Arch Ital Urol Androl; 2005 Dec; 77(4):206-10. PubMed ID: 16444934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
